Durable bleed protection for all bleeding subtypes and favorable safety over 5 years (end-of-study) in the Phase 3 HOPE-B trial for persons with severe or moderately severe Haemophilia B

Name: Durable bleed protection for all bleeding subtypes and favorable safety over 5 years (end-of-study) in the Phase 3 HOPE-B trial for persons with severe or moderately severe Haemophilia B
Start: 2026-02-06T09:06:00Z
End: 2026-02-06T09:15:00Z